In this section:
National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early Development Years of the Newborn
These nationally agreed clinical guidelines are intended to support a range of health care workers who care for women with drug and alcohol use issues, and their infants and families.
They have been developed through a process based on evidence reviews and expert consensus.
The drugs covered include: opioids, alcohol, tobacco, cannabis, amphetamines, cocaine, benzodiazepines, inhalants.
Other topics covered are: breastfeeding, vertical transmission of blood-borne viruses, psychosocial aspects, obstetric implications, pain management in labour and early childhood development. Aboriginal and Torres Strait Islander issues are also addressed.
| Download: | Clinical Guidelines - Drug Use During Pregnancy, Birth, Early Development (PDF File - 1154k) |
